|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Loss from continuing operations, net of tax | |||||
| Net income from discontinued operations, net of tax | |||||
| Total net income | |||||
| Gain on sale of discontinued operations, net of tax | |||||
| Depreciation and amortization | |||||
| Stock based compensation | |||||
| Change in expected credit losses | |||||
| Loss on disposal of equipment | |||||
| Deferred taxes | |||||
| Provision for credit losses | |||||
| Accounts receivable | |||||
| Other assets | |||||
| Prepaid expenses and other assets | |||||
| Right of use asset | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Deferred tax liability | |||||
| Operating lease liability | |||||
| Income taxes payable | |||||
| Changes in assets and liabilities of discontinued operations | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures | |||||
| Net proceeds from sale of discontinued operation | |||||
| Purchase of marketable securities | |||||
| Sale of marketable securities | |||||
| Equity investment | |||||
| Cash used in investing activities of discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Repayments of finance lease obligations related party | |||||
| Repayments of finance lease obligations | |||||
| Cash settlement of warrants | |||||
| Costs paid in connection with tender offer and other | |||||
| Proceeds from stock option exercises | |||||
| Cash used in financing activities of discontinued operations | |||||
| Net cash used in financing activities | |||||
| Decrease in Cash and Cash Equivalents | |||||
| Effect of exchange rates on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Cash and cash equivalents | |||||
| Escrow funds receivable | |||||
| Cash, cash equivalents, and restricted cash | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Assets acquired by operating lease | |||||
| Reclassification of warrants from equity to liability | |||||
| Tender offer costs included in accounts payable and accrued expenses | |||||
| Assets acquired by operating lease related to discontinued operations | |||||
Loading...